Louis J. Dell’iTalia
Research Subjects
Louis J. Dell’iTalia has a total of 157 co-authors. Here are the top co-authors by number of shared publications:
Betty Pat
Birmingham Veterans Affairs Health Care System
11 shared publicationsJames F. Collawn
UAB Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, Ala
10 shared publicationsJames E. Davies
Department of Surgery, Division of Thoracic and Cardiovascular Surgery, UAB, USA
8 shared publicationsMustafa I. Ahmed
Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, United States
7 shared publicationsPamela C. Powell
Department of Veterans Affairs Medical Center, Birmingham, Ala
7 shared publicationsCarlos M. Ferrario
Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, United States
6 shared publications
Latest Publications
- Open Access
- 18 November 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (22) , e043558
Persistent Shift in Principal Strain Angles and Postsurgical Decline in Left Ventricular Ejection Fraction in Patients With Primary Mitral Regurgitation
Background: The double helical direction of myocardial fibers allows for left ventricular (LV) twist. This led to the hypothesis that principal strain angles determine LV functional recovery after mitral valve repair in patients with primary mitral regurgitation (PMR). Methods: Controls (n=52) and patients with PMR with regurgitant volume defined as mild (<30 mL, n=16), moderate (30–50 mL, n=38), and severe (50 mL, n=55) had cardiac magnetic resonance with tissue tagging and 3‐dimensional analysis. Fifty‐four patients with PMR had presurgery and 6 (n=46), 12 (n=44), and 24 (n=25) month studies. Longitudinal, circumferential, and maximal shortening were computed along with principal strain angles (circumferential, longitudinal, and radial directions) at base, mid, and distal LV levels. Results: LV ejection fraction did not differ in mild, moderate, and severe PMR with similar increases in mid LV 3‐dimensional radius‐to‐wall thickness and decrease in LV mass to volume and sphericity index versus controls. Radial longitudinal shear strain and LV mid and distal LV circumferential and longitudinal angles increased in all groups with PMR. Postsurgery LV end‐diastolic volume, LV end‐diastolic mass to volume and 3‐dimensional radius‐to‐wall thickness returned to normal at 6, 12, and 24 months; however, mid LV circumferential, longitudinal, and maximal shortening decreased below normal. LV circumferential and longitudinal angles and LV sphericity index did not change from presurgery whereas LV ejection fraction post surgery correlated with decrease in LV twist at 6, 12, and 24 months. Conclusions: Changes in principle strain angles occur early in PMR. The extent to which they persist after surgery may underlie the decrease in LV ejection fraction.
- 18 November 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (22) , e043558
Open AccessPersistent Shift in Principal Strain Angles and Postsurgical Decline in Left Ventricular Ejection Fraction in Patients With Primary Mitral Regurgitation
Background: The double helical direction of myocardial fibers allows for left ventricular (LV) twist. This led to the hypothesis that principal strain angles determine LV functional recovery after mitral valve repair in patients with primary mitral regurgitation (PMR). Methods: Controls (n=52) and patients with PMR with regurgitant volume defined as mild (<30 mL, n=16), moderate (30–50 mL, n=38), and severe (50 mL, n=55) had cardiac magnetic resonance with tissue tagging and 3‐dimensional analysis. Fifty‐four patients with PMR had presurgery and 6 (n=46), 12 (n=44), and 24 (n=25) month studies. Longitudinal, circumferential, and maximal shortening were computed along with principal strain angles (circumferential, longitudinal, and radial directions) at base, mid, and distal LV levels. Results: LV ejection fraction did not differ in mild, moderate, and severe PMR with similar increases in mid LV 3‐dimensional radius‐to‐wall thickness and decrease in LV mass to volume and sphericity index versus controls. Radial longitudinal shear strain and LV mid and distal LV circumferential and longitudinal angles increased in all groups with PMR. Postsurgery LV end‐diastolic volume, LV end‐diastolic mass to volume and 3‐dimensional radius‐to‐wall thickness returned to normal at 6, 12, and 24 months; however, mid LV circumferential, longitudinal, and maximal shortening decreased below normal. LV circumferential and longitudinal angles and LV sphericity index did not change from presurgery whereas LV ejection fraction post surgery correlated with decrease in LV twist at 6, 12, and 24 months. Conclusions: Changes in principle strain angles occur early in PMR. The extent to which they persist after surgery may underlie the decrease in LV ejection fraction.
- Open Access
Persistent Shift in Laminar Planes Contribute to Post-Surgical Decline in LVEF in Patients with Primary Mitral Regurgitation
Background: The double helical direction of LV laminar sheets from endocardium to epicardium allows for wringing motion or LV twist. This provides a major component to LV wall thickening, stroke volume, and ejection fraction (EF). When this laminar sheet arrangement changes in Primary Mitral Regurgitation (PMR) and whether it reverts to normal after mitral valve repair is unknown. Methods: Normal subjects (n=55) PMR patients had cardiac magnetic resonance imaging (CMR) with tissue tagging and 3-dimensional (3-D) analysis. They were grouped as asymptomatic moderate (n=23) and severe PMR (n=25) by regurgitant volume (RV) and pre-surgery (n=54) with post-surgery follow up at six, 12, and 24 months. Amplitude and directional vector of longitudinal (Ell), circumferential (Ecc), and maximal shortening were computed along with principle strain angles (Ecc°, Ell°, and Err°) at basal, mid, and distal LV levels. Results: Asymptomatic moderate (RV 35 ± 16 ml; LVEF 62 ± 6%) and severe (RV 55 ±16 ml; LVEF 63 ± 6%) and symptomatic pre-surgery (RV 61 ± 29 ml; LVEF 63 ± 8%) had similar increases in mid LV 3-D radius to wall thickness (R/T), decrease in LV mass to volume (M/V) and sphericity index (SI) vs. normal. Radial longitudinal shear strain and mid LV Ecc° and EII° angles increased in all PMR groups, consistent with a shift in LV laminar plane direction and decreased LV SI. Post-surgery, LV end-diastolic (ED) volume, LVED M/V and 3-D R/T returned to normal within two years; however, mid LV circumferential, longitudinal, and maximal shortening decrease below normal. LV Ecc° and Ell° angles, and SI are unchanged from pre-surgery. LVEF decreased post-surgery and had a negative correlation with LV twist at six (r 2 = 0.30, p < 0.001), 12, (r 2 = 0.33, p < 0.001) and 24 months (r 2 = 0.38, p < 0.001) post-surgery. Conclusion: Early changes in Ecc° and Ell° angles, radial longitudinal shear strain, and LV spherical dilatation are consistent with a shift of LV laminar planes that persists after surgery. The extent to which this affects LV twist may underlie a heretofore explanation underlying the decrease in LVEF after surgery for PMR.
Open AccessPersistent Shift in Laminar Planes Contribute to Post-Surgical Decline in LVEF in Patients with Primary Mitral Regurgitation
Background: The double helical direction of LV laminar sheets from endocardium to epicardium allows for wringing motion or LV twist. This provides a major component to LV wall thickening, stroke volume, and ejection fraction (EF). When this laminar sheet arrangement changes in Primary Mitral Regurgitation (PMR) and whether it reverts to normal after mitral valve repair is unknown. Methods: Normal subjects (n=55) PMR patients had cardiac magnetic resonance imaging (CMR) with tissue tagging and 3-dimensional (3-D) analysis. They were grouped as asymptomatic moderate (n=23) and severe PMR (n=25) by regurgitant volume (RV) and pre-surgery (n=54) with post-surgery follow up at six, 12, and 24 months. Amplitude and directional vector of longitudinal (Ell), circumferential (Ecc), and maximal shortening were computed along with principle strain angles (Ecc°, Ell°, and Err°) at basal, mid, and distal LV levels. Results: Asymptomatic moderate (RV 35 ± 16 ml; LVEF 62 ± 6%) and severe (RV 55 ±16 ml; LVEF 63 ± 6%) and symptomatic pre-surgery (RV 61 ± 29 ml; LVEF 63 ± 8%) had similar increases in mid LV 3-D radius to wall thickness (R/T), decrease in LV mass to volume (M/V) and sphericity index (SI) vs. normal. Radial longitudinal shear strain and mid LV Ecc° and EII° angles increased in all PMR groups, consistent with a shift in LV laminar plane direction and decreased LV SI. Post-surgery, LV end-diastolic (ED) volume, LVED M/V and 3-D R/T returned to normal within two years; however, mid LV circumferential, longitudinal, and maximal shortening decrease below normal. LV Ecc° and Ell° angles, and SI are unchanged from pre-surgery. LVEF decreased post-surgery and had a negative correlation with LV twist at six (r 2 = 0.30, p < 0.001), 12, (r 2 = 0.33, p < 0.001) and 24 months (r 2 = 0.38, p < 0.001) post-surgery. Conclusion: Early changes in Ecc° and Ell° angles, radial longitudinal shear strain, and LV spherical dilatation are consistent with a shift of LV laminar planes that persists after surgery. The extent to which this affects LV twist may underlie a heretofore explanation underlying the decrease in LVEF after surgery for PMR.
- Open Access
- 14 October 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1410859
Imminent risk of LVEF decline in asymptomatic patients with primary mitral regurgitation
Background: 2020 American College of Cardiology/American Heart Association (ACC/AHA) Guidelines state that the ideal time for mitral valve surgery in primary mitral regurgitation (PMR) is when the LV approaches but has not yet reached echocardiographic LV ejection fraction (EF) < 60% or LV end-systolic dimension (ESD) > 40 mm. However, it is difficult to know the imminent risk of crossing this threshold when the surgical outcome is less optimal.Objective: Using machine learning and statistical models, we have shown that cardiac magnetic resonance (CMR) LV sphericity index (SI) and LV mid circumferential strain rate (SRcirc) added to LVEF and LVESD predict LVEF < 50% after mitral valve surgery. Here we test the hypothesis that these CMR features predict LVEF < 60% in asymptomatic PMR patients at 18 months.Methods: 33 asymptomatic PMR patients with moderate to severe mitral regurgitation had CMR with tissue tagging at baseline and every 6 months for 18 months. Two types of models were employed to predict LVEF < 60% at 18 months: a model using CMR features at a single time point (e.g., baseline) and a model utilizing repeated measurements over time.Results: CMR LVEF decreased below 60% in 13 patients over 18 months. LVEF varied over time with an inverse relation to mean arterial pressure and mean end-systolic wall stress. Random Forest models utilizing LV SI, LV mid SRcirc, LVESD, and LVEF at a single time point (baseline) had a predictive accuracy of 64%. LV SI, LV mid SRcirc, LVESD and LVEF at baseline, 6, and 12 months achieved a higher predictive accuracy of 79%, improved sensitivity from 57% to 85% than baseline alone and identified a threshold of CMR LVEF 63%–64% signaling LVEF < 60%.Conclusion: The variability of LVEF due to blood pressure dependence may require a longitudinal study that incorporates LVEF, LVESD, SRcirc at multiple time points to identify the threshold at which LVEF is at risk for decline to less than 60%.
- 14 October 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1410859
Open AccessImminent risk of LVEF decline in asymptomatic patients with primary mitral regurgitation
Background: 2020 American College of Cardiology/American Heart Association (ACC/AHA) Guidelines state that the ideal time for mitral valve surgery in primary mitral regurgitation (PMR) is when the LV approaches but has not yet reached echocardiographic LV ejection fraction (EF) < 60% or LV end-systolic dimension (ESD) > 40 mm. However, it is difficult to know the imminent risk of crossing this threshold when the surgical outcome is less optimal.Objective: Using machine learning and statistical models, we have shown that cardiac magnetic resonance (CMR) LV sphericity index (SI) and LV mid circumferential strain rate (SRcirc) added to LVEF and LVESD predict LVEF < 50% after mitral valve surgery. Here we test the hypothesis that these CMR features predict LVEF < 60% in asymptomatic PMR patients at 18 months.Methods: 33 asymptomatic PMR patients with moderate to severe mitral regurgitation had CMR with tissue tagging at baseline and every 6 months for 18 months. Two types of models were employed to predict LVEF < 60% at 18 months: a model using CMR features at a single time point (e.g., baseline) and a model utilizing repeated measurements over time.Results: CMR LVEF decreased below 60% in 13 patients over 18 months. LVEF varied over time with an inverse relation to mean arterial pressure and mean end-systolic wall stress. Random Forest models utilizing LV SI, LV mid SRcirc, LVESD, and LVEF at a single time point (baseline) had a predictive accuracy of 64%. LV SI, LV mid SRcirc, LVESD and LVEF at baseline, 6, and 12 months achieved a higher predictive accuracy of 79%, improved sensitivity from 57% to 85% than baseline alone and identified a threshold of CMR LVEF 63%–64% signaling LVEF < 60%.Conclusion: The variability of LVEF due to blood pressure dependence may require a longitudinal study that incorporates LVEF, LVESD, SRcirc at multiple time points to identify the threshold at which LVEF is at risk for decline to less than 60%.
- Open Access
Contributions of mechanical loading and hormonal changes to eccentric hypertrophy during volume overload: a Bayesian analysis using logic-based network models
Primary mitral regurgitation (MR) is a pathology that alters mechanical loading on the left ventricle and induces a distinctive ventricular remodeling response known as eccentric hypertrophy. Drug therapies may alleviate symptoms, but only mitral valve repair can provide significant recovery of cardiac function and dimensions. However, 20% of patients still develop systolic dysfunction post-operatively despite being treated according to the current guidelines. Thus, better understanding of the hypertrophic process in the setting of ventricular volume overload (VO) is needed to improve and better personalize the management of MR. To address this knowledge gap, we employ a Bayesian approach to combine data from 70 studies on experimental volume overload in dogs and rats and use it to calibrate a logic-based network model of hypertrophic signaling in myocytes. The calibrated model suggests that growth in experimental VO is mostly driven by the neurohormonal response, with an initial increase in myocardial tissue stretch being compensated by subsequent remodeling fairly early in the time course of VO. This observation contrasts with a common perception that volume-overload hypertrophy is driven primarily by increased myocyte strain. The model suggests that Endothelin1 receptor activity plays a central role in driving hypertrophic responses and the activation of the fetal gene program. The model reproduces a number of responses to drug therapy not used in its calibration, and predicts that a combination of endothelin receptor antagonist and angiotensin receptor blockers would have the greatest potential to dampen cardiomyocyte hypertrophy and dysfunction in VO. Author Summary Mitral valve regurgitation is a common heart disease in which a malfunctioning valve allows part of the blood pumped by the heart to flow in the wrong direction. This condition overloads the heart by making it pump more blood volume than normal; the heart temporarily adapts by growing in mass and volume, but if untreated the condition can ultimately lead to heart failure and death. The most effective treatment is to surgically repair the valve; however, in many patients heart function deteriorates even after a successful surgery. Many researchers have studied this condition by experimentally overloading the hearts of dogs and rats, producing large amounts of data on the resulting geometric, mechanical, and biologic changes. Yet there is no clear answer on how to prevent the progression of the disease. In this work we integrate experimental data reported from 70 research articles on experimental volume overload through a simple model of heart mechanics and a more complex model of the molecular signaling pathways inside heart cells. We use a statistical approach to calibrate the computational model, so that it can predict not only average responses but also the degree of expected uncertainty for each prediction. We then use the model to explore how the heart responds to potential treatments during overload.
Open AccessContributions of mechanical loading and hormonal changes to eccentric hypertrophy during volume overload: a Bayesian analysis using logic-based network models
Primary mitral regurgitation (MR) is a pathology that alters mechanical loading on the left ventricle and induces a distinctive ventricular remodeling response known as eccentric hypertrophy. Drug therapies may alleviate symptoms, but only mitral valve repair can provide significant recovery of cardiac function and dimensions. However, 20% of patients still develop systolic dysfunction post-operatively despite being treated according to the current guidelines. Thus, better understanding of the hypertrophic process in the setting of ventricular volume overload (VO) is needed to improve and better personalize the management of MR. To address this knowledge gap, we employ a Bayesian approach to combine data from 70 studies on experimental volume overload in dogs and rats and use it to calibrate a logic-based network model of hypertrophic signaling in myocytes. The calibrated model suggests that growth in experimental VO is mostly driven by the neurohormonal response, with an initial increase in myocardial tissue stretch being compensated by subsequent remodeling fairly early in the time course of VO. This observation contrasts with a common perception that volume-overload hypertrophy is driven primarily by increased myocyte strain. The model suggests that Endothelin1 receptor activity plays a central role in driving hypertrophic responses and the activation of the fetal gene program. The model reproduces a number of responses to drug therapy not used in its calibration, and predicts that a combination of endothelin receptor antagonist and angiotensin receptor blockers would have the greatest potential to dampen cardiomyocyte hypertrophy and dysfunction in VO. Author Summary Mitral valve regurgitation is a common heart disease in which a malfunctioning valve allows part of the blood pumped by the heart to flow in the wrong direction. This condition overloads the heart by making it pump more blood volume than normal; the heart temporarily adapts by growing in mass and volume, but if untreated the condition can ultimately lead to heart failure and death. The most effective treatment is to surgically repair the valve; however, in many patients heart function deteriorates even after a successful surgery. Many researchers have studied this condition by experimentally overloading the hearts of dogs and rats, producing large amounts of data on the resulting geometric, mechanical, and biologic changes. Yet there is no clear answer on how to prevent the progression of the disease. In this work we integrate experimental data reported from 70 research articles on experimental volume overload through a simple model of heart mechanics and a more complex model of the molecular signaling pathways inside heart cells. We use a statistical approach to calibrate the computational model, so that it can predict not only average responses but also the degree of expected uncertainty for each prediction. We then use the model to explore how the heart responds to potential treatments during overload.
- Open Access
- 1 May 2024
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 4 (3) , oeae034
Gene expression and ultra-structural evidence for metabolic derangement in the primary mitral regurgitation heart
Chronic neurohormonal activation and hemodynamic load cause derangement in myocardial substrate utilization. We test the hypothesis that the primary mitral regurgitation heart (PMR) heart shows altered metabolic gene profile and cardiac ultrastructure consistent with decreased fatty acid and glucose metabolism despite LVEF > 60%. Metabolic gene expression in right atrial (RA), left atrial (LA), and left ventricular (LV) biopsies from donor hearts (n = 10) and from patients with moderate to severe PMR (n = 11) at surgery showed decreased mRNA glucose transporter type 4 (GLUT-4), GLUT-1 and insulin receptor substrate 2 and increased mRNA hexokinase 2, O-linked N-acetylglucosamine transferase and O-GlcNAcase, rate-limiting steps in the hexosamine biosynthetic pathway. Pericardial fluid levels of Neuropeptide Y were 4-fold higher than simultaneous plasma indicative of increased sympathetic drive. Quantitative TEM shows glycogen accumulation, glycophagy, increased lipid droplets, and mitochondrial cristae lysis. These findings are associated with increased mRNA for glycogen synthase kinase 3β, decreased carnitine palmitoyl transferase 2, and fatty acid synthase in PMR vs. normals. Cardiac magnetic resonance/positron emission tomography for 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) uptake showed decreased LV [18F]FDG uptake and increased plasma HbA1c, free fatty acids, mtDAMPs in a separate cohort of stable moderate PMR patients with LVEF > 60% (n = 8) vs. normal controls (n = 8). The PMR heart has a global ultrastructural and metabolic gene expression pattern of decreased glucose uptake along with increased glycogen and lipid droplets. Further studies must determine whether this presentation is an adaptation or maladaptation in the PMR heart in the clinical evaluation of PMR.
- 1 May 2024
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 4 (3) , oeae034
Open AccessGene expression and ultra-structural evidence for metabolic derangement in the primary mitral regurgitation heart
Chronic neurohormonal activation and hemodynamic load cause derangement in myocardial substrate utilization. We test the hypothesis that the primary mitral regurgitation heart (PMR) heart shows altered metabolic gene profile and cardiac ultrastructure consistent with decreased fatty acid and glucose metabolism despite LVEF > 60%. Metabolic gene expression in right atrial (RA), left atrial (LA), and left ventricular (LV) biopsies from donor hearts (n = 10) and from patients with moderate to severe PMR (n = 11) at surgery showed decreased mRNA glucose transporter type 4 (GLUT-4), GLUT-1 and insulin receptor substrate 2 and increased mRNA hexokinase 2, O-linked N-acetylglucosamine transferase and O-GlcNAcase, rate-limiting steps in the hexosamine biosynthetic pathway. Pericardial fluid levels of Neuropeptide Y were 4-fold higher than simultaneous plasma indicative of increased sympathetic drive. Quantitative TEM shows glycogen accumulation, glycophagy, increased lipid droplets, and mitochondrial cristae lysis. These findings are associated with increased mRNA for glycogen synthase kinase 3β, decreased carnitine palmitoyl transferase 2, and fatty acid synthase in PMR vs. normals. Cardiac magnetic resonance/positron emission tomography for 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) uptake showed decreased LV [18F]FDG uptake and increased plasma HbA1c, free fatty acids, mtDAMPs in a separate cohort of stable moderate PMR patients with LVEF > 60% (n = 8) vs. normal controls (n = 8). The PMR heart has a global ultrastructural and metabolic gene expression pattern of decreased glucose uptake along with increased glycogen and lipid droplets. Further studies must determine whether this presentation is an adaptation or maladaptation in the PMR heart in the clinical evaluation of PMR.
- Open Access
Chymase in Plasma and Urine Extracellular Vesicles: Novel Biomarkers for Primary Hypertension
BACKGROUND: Extracellular vesicles (EVs) have emerged as a promising liquid biopsy for various diseases. For the first time, using plasma and urinary EVs, we assessed the activity of renin-angiotensin system (RAS), a central regulator of renal, cardiac, and vascular physiology, in patients with control (Group I) or uncontrolled (Group II) primary hypertension. METHODS: EVs were isolated from 34 patients with history of hypertension, and characterized for size and concentration by nanoparticle tracking analyses, exosomal biomarkers by immunogold labeling coupled with transmission electron microscopy, flow cytometry and immunoblotting. EVs were analyzed for the hydrolytic activity of chymase, angiotensin converting enzyme (ACE), ACE2, and neprilysin (NEP) by HPLC. RESULTS: Plasma and urinary EVs were enriched for small EVs and expressed exosomal markers (CD63, CD9, and CD81). The size of urinary EVs (but not plasma EVs) was significantly larger in Group II compared to Group I. Differential activity of RAS enzymes was observed, with significantly higher chymase activity compared to ACE, ACE2, and NEP in plasma EVs. Similarly, urinary EVs exhibited higher chymase and NEP activity compared to ACE and ACE2 activity. Importantly, compared to Group I, significantly higher chymase activity was observed in urinary EVs (p = 0.03) from Group II, while no significant difference in activity was observed for other RAS enzymes. CONCLUSIONS: Bioactive RAS enzymes are present in plasma and urinary EVs. Detecting chymase in plasma and urinary EVs uncovers a novel mechanism of angiotensin II-forming enzyme and could also mediate cell-cell communication and modulate signaling pathways in recipient cells. GRAPHICAL
Open AccessChymase in Plasma and Urine Extracellular Vesicles: Novel Biomarkers for Primary Hypertension
BACKGROUND: Extracellular vesicles (EVs) have emerged as a promising liquid biopsy for various diseases. For the first time, using plasma and urinary EVs, we assessed the activity of renin-angiotensin system (RAS), a central regulator of renal, cardiac, and vascular physiology, in patients with control (Group I) or uncontrolled (Group II) primary hypertension. METHODS: EVs were isolated from 34 patients with history of hypertension, and characterized for size and concentration by nanoparticle tracking analyses, exosomal biomarkers by immunogold labeling coupled with transmission electron microscopy, flow cytometry and immunoblotting. EVs were analyzed for the hydrolytic activity of chymase, angiotensin converting enzyme (ACE), ACE2, and neprilysin (NEP) by HPLC. RESULTS: Plasma and urinary EVs were enriched for small EVs and expressed exosomal markers (CD63, CD9, and CD81). The size of urinary EVs (but not plasma EVs) was significantly larger in Group II compared to Group I. Differential activity of RAS enzymes was observed, with significantly higher chymase activity compared to ACE, ACE2, and NEP in plasma EVs. Similarly, urinary EVs exhibited higher chymase and NEP activity compared to ACE and ACE2 activity. Importantly, compared to Group I, significantly higher chymase activity was observed in urinary EVs (p = 0.03) from Group II, while no significant difference in activity was observed for other RAS enzymes. CONCLUSIONS: Bioactive RAS enzymes are present in plasma and urinary EVs. Detecting chymase in plasma and urinary EVs uncovers a novel mechanism of angiotensin II-forming enzyme and could also mediate cell-cell communication and modulate signaling pathways in recipient cells. GRAPHICAL
- 28 August 2023
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 9 (8) , 1717-1718
Time to Connect Pathophysiology and State-of-the-Art Imaging
- 28 August 2023
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 9 (8) , 1717-1718
Time to Connect Pathophysiology and State-of-the-Art Imaging
- 3 August 2023
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 208, 126-133
Elevated cardiac hemoglobin expression is associated with a pro-oxidative and inflammatory environment in primary mitral regurgitation
- 3 August 2023
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 208, 126-133
Elevated cardiac hemoglobin expression is associated with a pro-oxidative and inflammatory environment in primary mitral regurgitation
- Open Access
- 21 April 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10
Understanding post-surgical decline in left ventricular function in primary mitral regurgitation using regression and machine learning models
Background: Class I echocardiographic guidelines in primary mitral regurgitation (PMR) risks left ventricular ejection fraction (LVEF) < 50% after mitral valve surgery even with pre-surgical LVEF > 60%. There are no models predicting LVEF < 50% after surgery in the complex interplay of increased preload and facilitated ejection in PMR using cardiac magnetic resonance (CMR).Objective: Use regression and machine learning models to identify a combination of CMR LV remodeling and function parameters that predict LVEF < 50% after mitral valve surgery.Methods: CMR with tissue tagging was performed in 51 pre-surgery PMR patients (median CMR LVEF 64%), 49 asymptomatic (median CMR LVEF 63%), and age-matched controls (median CMR LVEF 64%). To predict post-surgery LVEF < 50%, least absolute shrinkage and selection operator (LASSO), random forest (RF), extreme gradient boosting (XGBoost), and support vector machine (SVM) were developed and validated in pre-surgery PMR patients. Recursive feature elimination and LASSO reduced the number of features and model complexity. Data was split and tested 100 times and models were evaluated via stratified cross validation to avoid overfitting. The final RF model was tested in asymptomatic PMR patients to predict post-surgical LVEF < 50% if they had gone to mitral valve surgery.Results: Thirteen pre-surgery PMR had LVEF < 50% after mitral valve surgery. In addition to LVEF (P = 0.005) and LVESD (P = 0.13), LV sphericity index (P = 0.047) and LV mid systolic circumferential strain rate (P = 0.024) were predictors of post-surgery LVEF < 50%. Using these four parameters, logistic regression achieved 77.92% classification accuracy while RF improved the accuracy to 86.17%. This final RF model was applied to asymptomatic PMR and predicted 14 (28.57%) out of 49 would have post-surgery LVEF < 50% if they had mitral valve surgery.Conclusions: These preliminary findings call for a longitudinal study to determine whether LV sphericity index and circumferential strain rate, or other combination of parameters, accurately predict post-surgical LVEF in PMR.
- 21 April 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10
Open AccessUnderstanding post-surgical decline in left ventricular function in primary mitral regurgitation using regression and machine learning models
Background: Class I echocardiographic guidelines in primary mitral regurgitation (PMR) risks left ventricular ejection fraction (LVEF) < 50% after mitral valve surgery even with pre-surgical LVEF > 60%. There are no models predicting LVEF < 50% after surgery in the complex interplay of increased preload and facilitated ejection in PMR using cardiac magnetic resonance (CMR).Objective: Use regression and machine learning models to identify a combination of CMR LV remodeling and function parameters that predict LVEF < 50% after mitral valve surgery.Methods: CMR with tissue tagging was performed in 51 pre-surgery PMR patients (median CMR LVEF 64%), 49 asymptomatic (median CMR LVEF 63%), and age-matched controls (median CMR LVEF 64%). To predict post-surgery LVEF < 50%, least absolute shrinkage and selection operator (LASSO), random forest (RF), extreme gradient boosting (XGBoost), and support vector machine (SVM) were developed and validated in pre-surgery PMR patients. Recursive feature elimination and LASSO reduced the number of features and model complexity. Data was split and tested 100 times and models were evaluated via stratified cross validation to avoid overfitting. The final RF model was tested in asymptomatic PMR patients to predict post-surgical LVEF < 50% if they had gone to mitral valve surgery.Results: Thirteen pre-surgery PMR had LVEF < 50% after mitral valve surgery. In addition to LVEF (P = 0.005) and LVESD (P = 0.13), LV sphericity index (P = 0.047) and LV mid systolic circumferential strain rate (P = 0.024) were predictors of post-surgery LVEF < 50%. Using these four parameters, logistic regression achieved 77.92% classification accuracy while RF improved the accuracy to 86.17%. This final RF model was applied to asymptomatic PMR and predicted 14 (28.57%) out of 49 would have post-surgery LVEF < 50% if they had mitral valve surgery.Conclusions: These preliminary findings call for a longitudinal study to determine whether LV sphericity index and circumferential strain rate, or other combination of parameters, accurately predict post-surgical LVEF in PMR.
- Open Access
- 12 April 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1132786
Impact of early pericardial fluid chymase activation after cardiac surgery
Introduction: Chymase is a highly destructive serine protease rapidly neutralized in the circulation by protease inhibitors. Here we test whether pericardial fluid (PCF) chymase activation and other inflammatory biomarkers determine intensive care unit length of stay, and explore mechanisms of chymase delivery by extracellular vesicles to the heart.Methods: PCF was collected from adult patients (17 on-pump; 13 off-pump) 4 h after cardiac surgery. Extracellular vesicles (EVs) containing chymase were injected into Sprague–Dawley rats to test for their ability to deliver chymase to the heart.Results: The mean intensive care unit (ICU) stay and mean total length of stay was 2.17 ± 3.8 days and 6.41 ± 1.3 days respectively. Chymase activity and 32 inflammatory markers did not differ in on-pump vs. off-pump cardiac surgery. Society of Thoracic Surgeons Predicted Risk of Morbidity and Mortality Score (STS-PROM), 4-hour post-surgery PCF chymase activity and C-X-C motif chemokine ligand 6 (CXCL6) were all independent predictors of ICU and total hospital length of stay by univariate analysis. Mass spectrometry of baseline PCF shows the presence of serine protease inhibitors that neutralize chymase activity. The compartmentalization of chymase within and on the surface of PCF EVs was visualized by immunogold labeling and transmission electron microscopy. A chymase inhibitor prevented EV chymase activity (0.28 fmol/mg/min vs. 14.14 fmol/mg/min). Intravenous injection of PCF EVs obtained 24 h after surgery into Sprague Dawley rats shows diffuse human chymase uptake in the heart with extensive cardiomyocyte damage 4 h after injection.Discussion: Early postoperative PCF chymase activation underscores its potential role in cardiac damage soon after on- or off-pump cardiac surgery. In addition, chymase in extracellular vesicles provides a protected delivery mechanism from neutralization by circulating serine protease inhibitors.
- 12 April 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1132786
Open AccessImpact of early pericardial fluid chymase activation after cardiac surgery
Introduction: Chymase is a highly destructive serine protease rapidly neutralized in the circulation by protease inhibitors. Here we test whether pericardial fluid (PCF) chymase activation and other inflammatory biomarkers determine intensive care unit length of stay, and explore mechanisms of chymase delivery by extracellular vesicles to the heart.Methods: PCF was collected from adult patients (17 on-pump; 13 off-pump) 4 h after cardiac surgery. Extracellular vesicles (EVs) containing chymase were injected into Sprague–Dawley rats to test for their ability to deliver chymase to the heart.Results: The mean intensive care unit (ICU) stay and mean total length of stay was 2.17 ± 3.8 days and 6.41 ± 1.3 days respectively. Chymase activity and 32 inflammatory markers did not differ in on-pump vs. off-pump cardiac surgery. Society of Thoracic Surgeons Predicted Risk of Morbidity and Mortality Score (STS-PROM), 4-hour post-surgery PCF chymase activity and C-X-C motif chemokine ligand 6 (CXCL6) were all independent predictors of ICU and total hospital length of stay by univariate analysis. Mass spectrometry of baseline PCF shows the presence of serine protease inhibitors that neutralize chymase activity. The compartmentalization of chymase within and on the surface of PCF EVs was visualized by immunogold labeling and transmission electron microscopy. A chymase inhibitor prevented EV chymase activity (0.28 fmol/mg/min vs. 14.14 fmol/mg/min). Intravenous injection of PCF EVs obtained 24 h after surgery into Sprague Dawley rats shows diffuse human chymase uptake in the heart with extensive cardiomyocyte damage 4 h after injection.Discussion: Early postoperative PCF chymase activation underscores its potential role in cardiac damage soon after on- or off-pump cardiac surgery. In addition, chymase in extracellular vesicles provides a protected delivery mechanism from neutralization by circulating serine protease inhibitors.